new post
StocksRunner logo
mail
search
 
menu
 
CorMedix
$6.78
-3.28%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

CRMD Stock Analysis & IQ Rating | CorMedix

 
 

CRMD

 

CorMedix

$6.78

 
-$0.23 | -3.28%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$17.43
 
 
MKT CAP
$534.19M
 
52W Low
$5.6
 
 
VOL
$2.80M
 
P/E Ratio
3.3
 
 
AVG VOL
$3.76M
 
RSI
22.40
 
 
TREND
Downtrend
 
 
 

CRMD Stock IQ

 
lock  Login to see CorMedix (CRMD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

CRMD Target Price

 
 
 

Strengths

 
 

CRMD Rewards

 Upgraded on attractively valued

CRMD Rewards

 Earnings are forecast to grow

CRMD Rewards

 Expands stock buyback program

CRMD Rewards

 Outperform the market

 
 

CRMD Price Performance

 
 

$12.02   (-43.59%)

$11.31   (-40.05%)

$13.99   (-51.54%)

$10.48   (-35.31%)

 
 
1year
6month
3month
1month
 

CRMD Analysts Opinion

 

CRMD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

CRMD Earnings Sentiment

 Above analyst estimates

CRMD Earnings Sentiment

 Earnings increase YoY

 
 

Rating

×
 

Rating

 

CRMD Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

CRMD Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

 

CRMD Activity Sentiment

 Expands stock buyback program

CRMD Activity Sentiment

 Investors confidence is positive

 

Future

×
 

Future

 

CRMD Future Sentiment

 Earnings are forecast to grow

CRMD Future Sentiment

 Outperform the market

 
 

CRMD Analysts Opinion

CRMD Analysts opinion is negative and it remained unchanged from the past 3 months

 

CRMD Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
73%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
NA
0%
0%
 

CRMD Street Sentiment 

CRMD Street Sentiment is bullish but have mixed views on the near-term outlook

 

CRMD Risk Level

 
 

CRMD has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

 
 

Risks Indicators

 Beta greater than 1.0

 
 
CRMD Risk Level
Fair
LOW
HIGH
 

CRMD Performance Sentiment

 
Sentiments overview associated with CRMD events and the stock performance.
 
 
73%
18%
Positive
Negative
8 out of 11
events present
2 out of 11
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Technical Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$6.78
 
Resistance
Price
 
$6.78
 
 
Current Price Range
 
$12.73
 
 
Show methods +
 
 
Linked to CRMD
IQ
Close Price
Change
 

TLPH

3.50

1.00

+0.76%

 
 
 
CRMD Latest Analysis +
 
 
FAQ About CRMD Stock Insights
 

What is CRMD current stock price?

What are CRMD stock strengths?

What is CRMD Risk Level?

What is CRMD market cap and volume?

What is CRMD current Stock IQ?

Should I buy CRMD stock right now?

Is CRMD a Strong Buy right now?

What does a 'Strong Buy' rating mean for CRMD?

What does a 'Strong Sell' rating mean for CRMD?

What factors influence CRMD's Stock IQ?

 
 
StocksRunner

Explore our CRMD Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored CRMD Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our CRMD Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Leaders
mail
 
 
 

CRMD

 

CorMedix

 
Set Alerts
 
 

Current Price

 

$6.78

 
-$0.23 | -3.28%
 
 
52W High
$17.43
 
 
MKT CAP
$534.19M
 
52W Low
$5.6
 
 
VOL
$2.80M
 
P/E Ratio
3.3
 
 
AVG VOL
$3.76M
 
RSI
22.40
 
 
TREND
Downtrend
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

CRMD Rewards

 Upgraded on attractively valued

CRMD Rewards

 Earnings are forecast to grow

CRMD Rewards

 Expands stock buyback program

CRMD Rewards

 Outperform the market

 
 
 

Linked to CRMD

 
 
 
Symbol
IQ
Close
Change
 

TLPH

3.50

1.00

+0.76%

 
 
 
 
 
user
 
 
 
 

CRMD Price Performance

 
 

$12.02   (-43.59%)

$11.31   (-40.05%)

$13.99   (-51.54%)

$10.48   (-35.31%)

 
 
1year
6month
3month
1month
 

CRMD Analysts Opinion

 

CRMD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

CRMD Earnings Sentiment

 Above analyst estimates

CRMD Earnings Sentiment

 Earnings increase YoY

 
 

Rating

×
 

Rating

 

CRMD Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

CRMD Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

 

CRMD Activity Sentiment

 Expands stock buyback program

CRMD Activity Sentiment

 Investors confidence is positive

 

Future

×
 

Future

 

CRMD Future Sentiment

 Earnings are forecast to grow

CRMD Future Sentiment

 Outperform the market

 
 

CRMD Analysts Opinion

CRMD Analysts opinion is negative and it remained unchanged from the past 3 months

 

CRMD Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
73%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
NA
0%
0%
 

CRMD Street Sentiment 

CRMD Street Sentiment is bullish but have mixed views on the near-term outlook

 

CRMD Risk Level

 
 

CRMD has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

 
 

Risks Indicators

 

 Beta greater than 1.0

 
 
CRMD Risk Level
Fair
LOW
HIGH
 
CRMD Performance Sentiment
 
Sentiments overview associated with CRMD events and the stock performance.
 
 
73%
18%
Positive
Negative
8 out of 11
events present
2 out of 11
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Technical Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$6.78
 
Resistance
Price
 
$6.78
 
 
Current Price Range
 
$12.73
 
 
Show methods +
 
 

Latest Analysts Recommendations

 
 
Date
Action
Rating
Firm
 

Dec 19, 2025

Reiterate

Buy

D. Boral Capital

 

Dec 08, 2025

Upgrade

Buy

Zacks

 

Nov 14, 2025

Reiterate

Buy

HC Wainwright & Co.

 

Nov 13, 2025

Reiterate

Buy

Needham

 

Nov 13, 2025

Reiterate

Buy

D. Boral Capital

 
 
 
 
 
 

CRMD Stock IQ

 
 
 
lock  Login to unlock CorMedix (CRMD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

CRMD Latest Analysis

 
 
 

Will DefenCath Continue to Aid CorMedixs Top Line in Q4 Earnings?. CRMDs DefenCath the only FDA-approved antimicrobial catheter lock saw higher outpatient dialysis use in the fourth quarter likely driving revenues.

 

Thu Jan 15, 2026

$7.01 | -1.13%
 
Activity

Breaking Update: Steven Lefkowitz Engages In Options Exercise At Cormedix Realizing $22K. A large exercise of company stock options by CRMD) was disclosed in a new SEC filing on January 15 as part of an insider exercise.United States Securities and Exchange Commission Lefkowitz Board Member at Cormedix executed a strategic derivative sale. This involved exercising stock options for 15000 shares of CRMD resulting in a transaction value of $22275.The Thursday morning update indicates Cormedix Inc

 

Thu Jan 15, 2026

$7.01 | -1.13%
 
Activity
Activity

CorMedix Inc. (CRMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.

 

Tue Jan 13, 2026

$7.06 | -1.26%
 
Activity

CorMedix Faces A Hard Reset As CMS Reimbursement Headwinds Emerge.

 

Fri Jan 9, 2026

$7.63 | +1.60%
 
Potential

CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference. ) a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions today announced that Joseph Todisco Chairman and CEO of CorMedix Therapeutics will present a corporate overview at the 44th annual J.P. Morgan Healthcare Conference. The presentation is scheduled to take place on Monday January 12 2026 at 4:30pm PST.

 

Fri Jan 9, 2026

$7.63 | +1.60%
 
Activity

CorMedix shares fall as 2026 revenue outlook disappoints (update).

 

Thu Jan 8, 2026

$7.51 | -32.77%
 
Activity
Momentum

CorMedix Therapeutics appoints Mike Seckler as chief commercial officer.

 

Thu Jan 8, 2026

$7.51 | -32.77%
 
Activity

Are Options Traders Betting on a Big Move in BCP Investment Stock?. Investors need to pay close attention to CorMedix (CRMD) stock based on the movements in the options market lately.

 

Fri Jan 2, 2026

$12.16 | +4.56%
 
Activity
 
 
 
 
 
StocksRunner

Discover CRMD Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of CRMD. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our CRMD Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CRMD Stock trends

CRMD Stock performance

CRMD Stock analysis

CRMD investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

CRMD Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing CRMD

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing CRMD

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.